A PHASE 4, OPEN-LABEL STUDY TO ASSESS THE FEASIBILITY AND EFFICACY ON MOTOR AND NON-MOTOR SYMPTOMS OF SWITCHING FROM PRAMIPEXOLE OR ROPINIROLE TO ROTIGOTINE TRANSDERMAL PATCH IN SUBJECTS WITH ADVANCED IDIOPATHIC PARKINSON'S DISEASE: